登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《LANCET，3月27日，Clinical and virological data of the first cases of COVID-19 in Europe: a case series》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-28

  • Clinical and virological data of the first cases of COVID-19 in Europe: a case series

    Prof Francois-Xavier Lescure, MD †

    Prof Lila Bouadma, MD †

    Duc Nguyen, MD

    Marion Parisey, MD

    Paul-Henri Wicky, MD

    Sylvie Behillil, PharmD

    et al.

    Published:March 27, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30200-0

    Summary

    Background

    On Dec 31, 2019, China reported a cluster of cases of pneumonia in people at Wuhan, Hubei Province. The responsible pathogen is a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report the relevant features of the first cases in Europe of confirmed infection, named coronavirus disease 2019 (COVID-19), with the first patient diagnosed with the disease on Jan 24, 2020.

  • 原文来源：https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30200-0/fulltext
167浏览量
原文链接
相关报告

  • 《SSRN，3月13日，Clinical Characteristics of 55 Cases of Deaths with COVID-19 Pneumonia in Wuhan, China: Retrospective Case Series》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-15
    • Clinical Characteristics of 55 Cases of Deaths with COVID-19 Pneumonia in Wuhan, China: Retrospective Case Series 18 Pages Posted: 13 Mar 2020 Tao Yao Wuhan University - Union Department of Infection Disease Yan Gao Wuhan University - Union Department of Infection Disease Abstract Background: With the widespread outbreak of (novel coronavirus disease 2019 ) COVID-19, more and more death cases were reported, however, limited data are available for the patients who died. We aimed to explore the epidemiological and clinical characteristics of deaths with COVID-19 pneumonia. Methods: This is a single-center retrospective study. We abstracted and analyzed epidemiological, demographic, clinical, and laboratory data from death cases with COVID-19 pneumonia in East hospital of Wuhan university Renmin hospital,between January 26, 2020, and February 18, 2020.
    214浏览量
    原文链接

  • 《LANCET，3月17日，COVID-19 in pregnant women – Authors' reply》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-18
    • COVID-19 in pregnant women – Authors' reply David Baud Eric Giannoni Léo Pomar Xiaolong Qi Karin Nielsen-Saines Didier Musso et al. Show all authors Published:March 17, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30192-4 We are grateful for the concerns of Manuel Schmidt and colleagues about our previous guidelines1 for pregnant women with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. At the time we developed the algorithm (February, 2020), there were no data regarding potential vertical transmission from infected mothers and outcomes in newborns. To date, there has been no evidence of vertical transmission of coronavirus disease 2019 (COVID-19) based on two small clinical series.2, 3 According to WHO, delayed umbilical cord clamping is highly unlikely to increase the risk of transmitting pathogens from the mother to the fetus even in the case of maternal infection.4 Because the vernix caseosa contains antimicrobial peptides, we recommend leaving it in place until 24 h after birth.5 New data examining neonates from infected mothers could be reassuring, but transmission after birth via contact with infectious respiratory secretions is still a concern, and physical separation of mother from child should be considered. Separation is a standard practice in pulmonary tuberculosis and is discussed in cases of maternal influenza infection.6 Therefore, separation of the mother and her newborn baby should be individually discussed by an interdisciplinary team, considering local facilities and risk factors for adverse neonatal outcomes, such as prematurity and fetal distress.
    101浏览量
    原文链接